We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

34 hedge funds and large institutions have $6.56M invested in Envoy Medical Warrant in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+34
Holders Change %
% of All Funds
0.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
34
Increased
Reduced
Closed
Calls
$6.2M
Puts
Net Calls
+$6.2M
Net Calls Change
+$6.2M
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$32K +$23.8K +33,333 New
AA
27
Ancora Advisors
Ohio
$22K +$17K +23,895 New
OCAM
28
Owl Creek Asset Management
New York
$16K +$11.9K +16,666 New
KTA
29
Keeley-Teton Advisors
Illinois
$15K +$11.2K +15,749 New
EC
30
EJF Capital
Virginia
$10K +$7.13K +10,000 New
RA
31
Ramius Advisors
New York
$10K +$7.28K +10,200 New
SGAM
32
Seaport Global Asset Management
New York
$2K +$1.43K +2,000 New
UBS Group
33
UBS Group
Switzerland
$2K +$1.5K +2,101 New
KJHP
34
K.J. Harrison & Partners
Ontario, Canada
$19 +$14.3K +20,000 New

COCHW Hedge Fund Activity: Q2 2021 in Review

34 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q2 2021, worth a combined $6.56M.

Buyers outnumbered sellers: 34 funds opened new COCHW positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Nomura Holdings, opening a new position worth an estimated $455K.

  • 34 institutional investors held Envoy Medical Warrant (COCHW) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $6.56M of Envoy Medical Warrant stock for Q2 2021.
  • 34 funds opened new Envoy Medical Warrant positions in Q2 2021 and 0 closed out, a net change of +34 holders.
  • The largest Envoy Medical Warrant buyer in Q2 2021 was Nomura Holdings, an estimated $455K added.

Based on aggregated 13F filings for Q2 2021.